We are live on ! Find out more
EVGN icon

Evogene
EVGN

15 hedge funds and large institutions have $409K invested in Evogene in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more capital invested

Capital invested by funds: $200K → $409K (+$209K)

17% less funds holding

Funds holding: 18 → 15 (-3)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
15
Holders Change
-3
Holders Change %
-16.67%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$431K
2
TSS
Two Sigma Securities
New York
+$11.8K
3
UBS Group
UBS Group
Switzerland
+$4.87K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$97.6K
2
Jane Street
Jane Street
New York
-$18.4K
3
XT
XTX Topco
Cayman Islands
-$9.41K
4
Morgan Stanley
Morgan Stanley
New York
-$4.91K
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$945
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$352K +$431K +456,587 New
Jane Street
2
Jane Street
New York
$14.2K -$18.4K -19,442 -51%
XT
3
XTX Topco
Cayman Islands
$9.79K -$9.41K -9,963 -44%
TSS
4
Two Sigma Securities
New York
$9.6K +$11.8K +12,465 New
DSC
5
Daytona Street Capital
Missouri
$7.7K – – –
BNP Paribas Financial Markets
6
BNP Paribas Financial Markets
France
$7.03K -$945 -1,000 -10%
UBS Group
7
UBS Group
Switzerland
$4.89K +$4.87K +5,155 +431%
Morgan Stanley
8
Morgan Stanley
New York
$2.96K -$4.91K -5,200 -57%
SPIA
9
Steward Partners Investment Advisory
New York
$389 – – –
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Quebec, Canada
$385 – – –
TCM
11
Tradewinds Capital Management
Washington
$101 – – –
Osaic Holdings
12
Osaic Holdings
Arizona
$77 -$47 -50 -33%
SS
13
SBI Securities
Japan
$55 – – –
SWM
14
SHP Wealth Management
Massachusetts
$50 – – –
Citadel Advisors
15
Citadel Advisors
Florida
– -$97.6K -88,764 Closed
AS
16
Altshuler Shaham
Israel
– -$825 -750 Closed
Bank of America
17
Bank of America
North Carolina
– -$175 -159 Closed
FFA
18
Farther Finance Advisors
California
– -$1 -1 Closed
Russell Investments Group
19
Russell Investments Group
United Kingdom
– -$1 -1 Closed

EVGN Hedge Fund Activity: Q1 2026 in Review

15 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q1 2026, worth a combined $409K — up 105% from $200K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of EVGN and 2 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 1 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $431K. The largest seller was Citadel Advisors, exiting entirely with an estimated $97.6K sold.

  • 15 institutional investors held Evogene (EVGN) as of Q1 2026, down from 18 in Q4 2025.
  • Funds reported $409K of Evogene stock for Q1 2026, up 105% quarter-over-quarter.
  • 2 funds opened new Evogene positions in Q1 2026 and 5 closed out, a net change of -3 holders.
  • The largest Evogene buyer in Q1 2026 was Armistice Capital, an estimated $431K added.
  • The largest Evogene seller in Q1 2026 was Citadel Advisors, an estimated $97.6K sold.

Based on aggregated 13F filings for Q1 2026.